DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

India Glycols Limited — Board Meeting Intimation

NSE 56 min ago·6 Nov 2026, 9:25 am

India Glycols

India Glycols Limited has announced that its board will meet on November 13, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026.

This update is significant for investors as it provides the first glimpse into the company's performance during the ongoing quarter. It will help gauge the demand for glycols and other chemicals in the market and assess the company's operational efficiency.

Investors should watch for key metrics such as revenue growth, profit margins, and any commentary on future outlook. The results will likely influence the stock's short-term price movement.